THER
Price:
$0.0001
Market Cap:
$615.15K
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable inform...[Read more]
Industry
Biotechnology
IPO Date
2010-04-01
Stock Exchange
PNK
Ticker
THER
According to Theralink Technologies, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.03. This represents a change of 156.59% compared to the average of 0.01 of the last 4 quarters.
The mean historical Current Ratio of Theralink Technologies, Inc. over the last ten years is 0.68. The current 0.03 Current Ratio has changed 366.67% with respect to the historical average. Over the past ten years (40 quarters), THER's Current Ratio was at its highest in in the December 2015 quarter at 4.14. The Current Ratio was at its lowest in in the December 2017 quarter at 0.00.
Average
0.68
Median
0.12
Minimum
0.00
Maximum
4.14
Discovering the peaks and valleys of Theralink Technologies, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.70%
Maximum Annual Current Ratio = 4.14
Minimum Annual Increase = -98.87%
Minimum Annual Current Ratio = 0.00
Year | Current Ratio | Change |
---|---|---|
2023 | 0.03 | -83.07% |
2022 | 0.19 | -3.39% |
2021 | 0.19 | -88.84% |
2020 | 1.74 | 44.70% |
2019 | 0.00 | -86.04% |
2018 | 0.03 | 2.82% |
2017 | 0.00 | -97.96% |
2016 | 0.05 | -98.87% |
2015 | 4.14 | 885.13% |
2014 | 0.42 | 2.18% |
The current Current Ratio of Theralink Technologies, Inc. (THER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.14
5-year avg
0.43
10-year avg
0.68
Theralink Technologies, Inc.’s Current Ratio is less than Adhera Therapeutics, Inc. (0), greater than GB Sciences, Inc. (0.00), greater than SciSparc Ltd. (0.02), less than Creative Medical Technology Holdings, Inc. (4.10), less than Regen BioPharma, Inc. (19.13), greater than Enzolytics Inc. (0.03), less than Sonnet BioTherapeutics Holdings, Inc. (0.98), less than Inhibikase Therapeutics, Inc. (1.65), less than Sio Gene Therapies Inc. (0.85), less than Kaleido Biosciences, Inc. (5.52), greater than Tempest Therapeutics, Inc. (0), less than Lexaria Bioscience Corp. (1.69), less than Navidea Biopharmaceuticals, Inc. (0), less than ZyVersa Therapeutics, Inc. (58.27), less than Biodexa Pharmaceuticals Plc (0.56), less than Oncorus, Inc. (0.03), less than null (2.16), less than null (1.74),
Company | Current Ratio | Market cap |
---|---|---|
0 | $17.33K | |
0.00 | $407.00 | |
0.02 | $2.54M | |
4.10 | $4.45M | |
19.13 | $851.41K | |
0.03 | $4.79M | |
0.98 | $2.50M | |
1.65 | $155.21M | |
0.85 | $0 | |
5.52 | $4.26K | |
0 | $39.52M | |
1.69 | $36.48M | |
0 | $100.08K | |
58.27 | $2.65M | |
0.56 | $2.32M | |
0.03 | $0 | |
2.16 | $0 | |
1.74 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralink Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theralink Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Theralink Technologies, Inc.'s Current Ratio?
How is the Current Ratio calculated for Theralink Technologies, Inc. (THER)?
What is the highest Current Ratio for Theralink Technologies, Inc. (THER)?
What is the 3-year average Current Ratio for Theralink Technologies, Inc. (THER)?
What is the 5-year average Current Ratio for Theralink Technologies, Inc. (THER)?
How does the current Current Ratio for Theralink Technologies, Inc. (THER) compare to its historical average?